Arrowstreet Capital’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.57M | Sell |
360,565
-755,494
| -68% | -$13.8M | ﹤0.01% | 1051 |
|
|
2025
Q1 | $22.1M | Sell |
1,116,059
-1,646,641
| -60% | -$32.7M | 0.02% | 570 |
|
|
2024
Q4 | $47.4M | Buy |
2,762,700
+1,013,456
| +58% | +$17.4M | 0.04% | 389 |
|
|
2024
Q3 | $35M | Buy |
1,749,244
+1,084,186
| +163% | +$21.7M | 0.03% | 409 |
|
|
2024
Q2 | $7.44M | Buy |
665,058
+599,100
| +908% | +$6.7M | 0.01% | 727 |
|
|
2024
Q1 | $435K | Buy |
+65,958
| New | +$435K | ﹤0.01% | 1468 |
|
|
2018
Q4 | – | Sell |
-16,400
| Closed | -$102K | – | 1325 |
|
|
2018
Q3 | $102K | Sell |
16,400
-7,700
| -32% | -$47.9K | ﹤0.01% | 1047 |
|
|
2018
Q2 | $108K | Buy |
+24,100
| New | +$108K | ﹤0.01% | 1032 |
|